Metraipolis › archive › dc_5259b6fc746c

Personalized mRNA Neoantigen Vaccines in Cancer: Linking Precision Antigen Selection, Immune Remodeling, and Checkpoint Blockade — Europe PMC PMID:42794593

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42794593
DOI: 10.3390/ijms27188163
License (as archived): solo-consultazione
Archived: 2026-10-10T02:37:10.146Z
SHA-256 of the archived text: 484bbc365c585bba3889f91c2a9a64b3e700bc7738bf8204d87f067eb50a52f7
Stable URL of this page: https://metraipolis.com/documento/dc_5259b6fc746c

How to cite

Personalized mRNA Neoantigen Vaccines in Cancer: Linking Precision Antigen Selection, Immune Remodeling, and Checkpoint Blockade — Europe PMC PMID:42794593 — Europe PMC (en), https://europepmc.org/article/MED/42794593 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5259b6fc746c (Metraipolis archive dc_5259b6fc746c, sha256 484bbc365c585bba3889f91c2a9a64b3e700bc7738bf8204d87f067eb50a52f7)

BibTeX

@misc{dc5259b6fc746c,
  title = {Personalized mRNA Neoantigen Vaccines in Cancer: Linking Precision Antigen Selection, Immune Remodeling, and Checkpoint Blockade — Europe PMC PMID:42794593},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794593},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5259b6fc746c; sha256 484bbc365c585bba3889f91c2a9a64b3e700bc7738bf8204d87f067eb50a52f7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794593. Agents can read the archived copy with the MCP tool read_document.